miRagen Therapeutics, Inc. (MGEN) Q2 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Dan Ferry – Managing Director-LifeSci Advisors, LLC Bill Marshall – President and Chief Executive Officer Jason Leverone – Chief Financial Officer Conference Call Participants Liana Moussatos – Wedbush Securities Jonathan Miller – Evercore ISI Jennifer Grayson – R. W. Baird Leland Gershell – Oppenheimer Suji Jeong – Jefferies Operator Greetings and welcome to the miRagen Therapeutics’ Q2 2019 Ea ...

Restoring Biological Harmony for Patients with Debilitating Disease Pg. 1 miRagen Therapeutics NASDAQ: MGEN Jefferies 2019 Healthcare Conference June 2019 Cautionary Note Regarding Forward-Looking Statements Pg. 2 This presentation contains forward-looking statements relating to Miragen Therapeutics, Inc., including statements about our plans to obtain funding, develop and commercialize our therapeutic candidates, our planned clinical trials, the timing of and our ability to obtain and maintain regulatory a ...

miRagen Therapeutics, Inc. (MGEN) Q1 2019 Results Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Dan Ferry - LifeSci Advisors Bill Marshall - President and Chief Executive Officer Jason Leverone - Chief Financial Officer Paul Rubin - Executive Vice President of Research and Development Adam Levy - Chief Business Officer Conference Call Participants Jonathan Miller - Evercore ISI Liana Moussatos - Wedbush Securities Eun Yang - Jefferies Madhu Kumar - Robert W. Baird George Zavoico - B. ...

Restoring Biological Harmony for Patients with Debilitating Disease Pg. 1 miRagen Therapeutics NASDAQ: MGEN Oppenheimer 29th Annual Healthcare Conference March 20, 2019 Cautionary Note Regarding Forward-Looking Statements Pg. 2 This presentation contains forward-looking statements relating to Miragen Therapeutics, Inc., including statements about our plans to obtain funding, develop and commercialize our therapeutic candidates, our planned clinical trials, the timing of and our ability to obtain and maintai ...

miRagen Therapeutics, Inc. (MGEN) Q4 2018 Earnings Conference Call March 13, 2019 4:30 PM ET Company Participants Daniel Ferry - LifeSci Advisors, LLC William Marshall - Co-Founder, President and Chief Executive Officer Jason Leverone - Chief Financial Officer Paul Rubin - Executive Vice President of Research and Development Adam Levy - Chief Business Officer Conference Call Participants Jonathan Miller - Evercore ISI Suji Jeong - Jefferies LLC Vasiliana Moussatos - Wedbush Securities Inc. Madhu Kumar - Rob ...